1. Voclosporin in lupus nephritis: a profile of its use

   • Esther S. Kim
   • Susan J. Keam

   Adis Drug Q&A 17 January 2022 Pages: 1 - 6

2. Glutamatergic modulators are poorly understood, but promising therapies in depressive disorders

   • Caroline Fenton
   • Arnold Lee

   Disease Management 27 November 2021 Pages: 7 - 12

3. Eczematous drug eruptions mostly manageable with emollients and corticosteroids

   • Caroline Fenton
   • Connie Kang

   Drug Reactions and Interactions 06 December 2021 Pages: 13 - 18

   

4. First reports of adverse drug reactions

   Drug Reactions and Interactions 03 January 2022 Pages: 19 - 20

5. A systematic review of the prevalence, determinants, and impact of potentially inappropriate prescribing in middle-aged adults

   • Michael Naughton
   • Frank Moriarty
   • Mariam Molokhia

   Review Article 21 January 2022 Pages: 21 - 32

   

6. The pharmacist survival guide: COVID-19 workflow modifications and crisis management in the surgical setting

   • Jawad N. Saleh

   Commentary 09 December 2021 Pages: 33 - 40

   

7. Frailty and rate of fractures in patients initiating antihypertensive medications: a cohort study in primary care

   • Marc F. Österdahl
   • Sarah-Jo Sinnott
   • Angel Wong

   Original Research Article 15 January 2022 Pages: 41 - 50

   

8. Antibiotic prescribing patterns for acute respiratory infections in a free clinic network: a pooled cross-sectional study

   • Anshul Daga
   • Oliver T. Nguyen
   • David B. Feller

   Short Communication 24 November 2021 Pages: 51 - 55